Jakub Trefler - Department of Rheumatoid Diseases Spartańska1, Institute of Rheumatology in Warsaw

基本信息

Career Trajectory

Bio

No content for now

Research Interests

Papers共 25 篇Author StatisticsCo-AuthorSimilar Experts

By YearBy Citation主题筛选期刊级别筛选合作者筛选合作机构筛选

Usability, Efficacy, and Safety of Candidate Tocilizumab Biosimilar CT-P47 Self-Administration Via Auto-Injector and Pre-Filled Syringe in Patients with Rheumatoid Arthritis: a Single-Arm, Open-Label, Phase 3 Study

Gerd Burmester,Piotr Adrian Klimiuk,Jakub Trefler,Janusz Jaworski,Sunghyun Kim,Yunju Bae,Dabee Jeon, Hyunseung Lee, Jiyoung Jang,Chankyoung Hwang, Hojae Lee,Josef S. Smolen

EXPERT REVIEW OF CLINICAL IMMUNOLOGY (2025)

Cited0Views0WOSBibtex

CT-P17 Adalimumab Biosimilar in Patients with Moderate-to-Severe Chronic Plaque Psoriasis: an Open-Label Extension of a Phase 3 Interchangeability Study

David M. Pariser,Mark G. Lebwohl, Janusz Jaworski,Jakub Trefler, Stefan Daniluk,Anna Dudek,Wojciech Baran, Witold Owczarek, Pawel Brzewski, Mariusz Sikora,Marek Krogulec, SungHyun Kim, JeeHye Suh, EunJin Choi, JungBin Cha, HyunJin Lee, SungJeong Lee, John Y. Koo

Dermatology and Therapyno. 5 (2025): 1079-1092

Cited0Views0WOSBibtex

Repeated Switching Between CT-P17 and EU Reference Adalimumab in Patients with Moderate-to-Severe Chronic Plaque Psoriasis: A Randomized, Double-Blind, Active-Controlled, Phase 3, Interchangeability Study

Mark G. Lebwohl, John Y. Koo,Janusz Jaworski,Jakub Trefler, Stefan Daniluk,Anna Dudek,Wojciech Baran,Witold Owczarek, Joanna Kolinek,Paweł Brzewski, Mariusz Sikora,Marek Krogulec,SungHyun Kim,YunJu Bae,DaBee Jeon,EunJin Choi,JungBin Cha, HyunJin Lee, SuJin Choi,David M. Pariser

Advances in Therapyno. 3 (2025): 1582-1599

Cited0Views0WOSBibtex

Smolen J.S.,Trefler J.,Racewicz A.,Jaworski J.,Zielinska A.,Krogulec M.,Jeka S., Wojciechowski R.,Kolossa K., Dudek A., Krajewska-Włodarczyk M.,Hrycaj P., Klimiuk P.A.,Burmester G.R., Kim S.H.,Bae Y., Jeon D., Yang G., Jung Y., Hong J.

Annals of the Rheumatic Diseases (2024): 749-750

Cited0Views0Bibtex

Efficacy and Safety of Candidate Biosimilar CT-P43 Versus Originator Ustekinumab in Moderate to Severe Plaque Psoriasis: 28-Week Results of a Randomised, Active-Controlled, Double-Blind, Phase III Study

Kim A. Papp,Mark G. Lebwohl,Diamant Thaçi,Janusz Jaworski,Bartlomiej Kwiek,Jakub Trefler,Anna Dudek,Jacek C. Szepietowski,Nataliya Reznichenko,Joanna Narbutt,Wojciech Baran, Joanna Kolinek, Stefan Daniluk,Katarzyna Bartnicka-Maslowska,Adam Reich, Yuriy Andrashko,Sunghyun Kim,Yunju Bae,Dabee Jeon, Jinsun Jung, Hyunseung Lee, Tina Pyo, Woori Ko

BIODRUGS（2024）

Cited2Views0WOSBibtex

Gerd Burmester,Jakub Trefler,Artur Racewicz,Janusz Jaworski,Agnieszka Zielinska,Marek Krogulec,Slawomir Jeka,Rafal Wojciechowski,Katarzyna Kolossa,Anna Dudek,Magdalena Krajewska-Wlodarczyk,Pawel Hrycaj,Piotr Adrian Klimiuk,SungHyun Kim,JeeHye Suh,Goeun Yang, Yunah Kim,YooBin Jung, Jiwoo Hong,Josef Smolen

ARTHRITIS & RHEUMATOLOGY (2024): 1017-1019

Cited0Views0Bibtex

POS0634 PHARMACOKINETICS, USABILITY AND SAFETY OF TOCILIZUMAB BIOSIMILAR (CT-P47) ADMINISTERED SUBCUTANEOUSLY BY AUTO-INJECTOR OR PRE-FILLED SYRINGE

Keystone E.,Burmester G.R.,Smolen J.S., Yu K.S., Ryu H.,Shin D., Park M., Hwang J., Moon S.J., Kim M., Klimiuk P.A.,Trefler J.,Jaworski J., Kim S.H.,Bae Y., Jeon D., Lee H., Jang J.,Bae J.

Annals of the Rheumatic Diseases (2024): 765-766

Cited0Views0Bibtex

No Progression of Radiographic Changes in the Sacroiliac Joints of a Patient with Non-Radiographic Axial Spondyloarthritis Treated with Secukinumab: A 6-Year Observation

Jakub Trefler, Karol Skopiński, Hubert Czaplicki,Katarzyna Życińska

Rheumatology (2024): 126-126

Cited0Views0Bibtex

Author Statistics

Co-Author

Co-Institution

D-Core

合作者
学生
导师

No result temporarily, you can search similar Scholar with the same research interest

Data Disclaimer

The page data are from open Internet sources, cooperative publishers and automatic analysis results through AI technology. We do not make any commitments and guarantees for the validity, accuracy, correctness, reliability, completeness and timeliness of the page data. If you have any questions, please contact us by email: report@aminer.cn